Study Finds Smokers Rarely Increase Smoking After Switching to Low-Nicotine Cigarettes

WINSTON-SALEM, N.C., July 15, 2026 — A new systematic review suggests that switching to cigarettes engineered with dramatically reduced nicotine is unlikely to trigger the kind of “behavioral compensation” that regulators fear. Published in JAMA Network Open, the study—led by researchers at Wake Forest University School of Medicine—finds little evidence that smokers increase cigarette consumption or smoke more intensely to recover nicotine delivery.

The review pooled results from 17 randomized clinical trials including more than 5,500 adolescents and adults. Across study designs, participants did not reliably escalate smoking to counteract nicotine reduction. Instead, many smokers reported or were observed to smoke fewer cigarettes after switching to very low nicotine products.

The findings are especially relevant to a proposed U.S. Food and Drug Administration product standard that would reduce nicotine levels in cigarettes and certain other combusted tobacco products to minimally or nonaddictive levels. Although the rule remains under FDA review, the core regulatory question is whether nicotine reduction would be undermined by compensatory changes in smoking behavior over time.

Lead author Rachel Denlinger-Apte, Ph.D., M.P.H., explains that this matters because nicotine is the addictive chemical driving tobacco dependence. Lowering nicotine may therefore help prevent new generations from becoming addicted and could also ease quitting by reducing withdrawal-related motivation.

A persistent concern has been confusion between truly low-nicotine cigarettes and older “light” cigarette designs. “Light” products are not meaningfully nicotine-reduced; they typically dilute smoke using ventilated filters, a strategy linked in past eras to compensatory smoking—such as taking more puffs or inhaling more deeply.

In contrast, the new evidence indicates that nicotine-lowered cigarettes do not replicate that compensation pattern. Across trials, none reported increases in the average number of cigarettes smoked per day among participants assigned to very low nicotine cigarettes.

Sixteen of 17 trials also found decreases in cigarettes per day relative to traditional cigarette conditions. Several studies additionally documented spontaneous quit attempts, suggesting that nicotine reduction may not only fail to provoke overuse, but may coincide with reduced dependence-driven smoking.

The review further reports no evidence of increases in carbon monoxide exposure, a common proxy for smoke uptake. After six weeks, fewer than 1% of participants were predicted to smoke more, reinforcing the overall conclusion that widespread compensation is unlikely.

Overall, the analysis strengthens the scientific rationale for nicotine product regulation. Tobacco use remains a major cause of preventable death, even as cigarette smoking rates fall, and policymakers are seeking tools that reduce addiction while supporting cessation.